IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Nephrocare Health Services
IPO is a MainBoard Upcoming IPO coming on
BSE,NSE with an
IPO
size of
[●]
.
This IPO falls under the
Healthcare sector, which has seen
28 IPOs
to date. Key sector metrics such as average PE ratio, IPO size, EBITDA margin,
and
PAT margin are compared below with the figures from the
Nephrocare Health Services
IPO.
Nephrocare Health Services IPO Peer Comparison with key metrics mentioned in the DRHP.
| Company Name | FV | PE | Revenue | Basic EPS | Diluted EPS | CMP | RoNW % | NAV |
|---|---|---|---|---|---|---|---|---|
| Nephrocare Health Services Limited | 2 | 755.81 | 8.28 | 8.01 | 13.19% | 59.56 | ||
| Narayana Health | 10 | 50.62 | 5482.98 | 38.9 | 38.9 | 1969.2 | ||
| Jupiter Life Line Hospitals Limited | 10 | 51.27 | 1261.54 | 29.47 | 29.47 | 1511 | 14.27% | 192.55 |
| Rainbow Children's Medicare Limited | 10 | 64 | 1515.87 | 23.97 | 23.84 | 1525.8 | 16.56% | 134.67 |
| Dr Agarwals Health Care Limited | 1 | 155.32 | 1711 | 2.8 | 2.78 | 431.8 | ||
| Vijaya Diagnostic Centre Limited | 10 | 73.1 | 681.39 | 13.95 | 13.92 | 1018.95 | ||
| Dr. Lal PathLabs Limited | 10 | 50.75 | 2461.4 | 58.48 | 58.48 | 2963.7 | 22.3% | 244.39 |
| Metropolis Healthcare Limited | 2 | 73.1 | 1331.2 | 28.29 | 28.15 | 2057.9 |
(1) Closing Price per share is closing price in NSE as on July 9, 2025.
(2) P/E is calculated as closing price / diluted EPS.
(3) For the Company, all the numbers have been taken from Restated Consolidated Financial Information. For others, all the numbers have been sourced from the F&S Report.
You can do performance analysis for Nephrocare Health IPO with Listed IPOs in the Healthcare sector and review their IPO performance based on Merchant banker, Listing price, IPO Valuation and other metrics.
This IPO report captures the post-listing performance of IPOs in the Healthcare sector, featuring key metrics like offer price, listing gain, and CMP to help investors assess return potential and sector sentiment.
| NAME | OFFER PRICE | LISTING PRICE | LISTING GAIN | CMP | CMP % |
|---|---|---|---|---|---|
|
Dr Agarwals
IPO
Financial Report >> |
₹ 402.00 | ₹ 402.00 | 0.00% | ₹ 445 | 11% |
|
Laxmi Dental
IPO
Financial Report >> |
₹ 428.00 | ₹ 542.00 | 26.64% | ₹ 426 | -1% |
|
Suraksha Diagnostic
IPO
Financial Report >> |
₹ 441.00 | ₹ 437.00 | -0.91% | ₹ 307 | -30% |
|
Sagility India
IPO
Financial Report >> |
₹ 30.00 | ₹ 29.36 | -2.13% | ₹ 43 | 45% |
|
GPT Healthcare
IPO
Financial Report >> |
₹ 186.00 | ₹ 200.75 | 7.93% | ₹ 167 | -10% |
|
Entero Healthcare
IPO
Financial Report >> |
₹ 1,258.00 | ₹ 1,149.50 | 1149.50% | ₹ 1,279 | 2% |
|
Honasa (Mamaearth)
IPO
Financial Report >> |
₹ 324.00 | ₹ 337.15 | 4.06% | ₹ 265 | -18% |
|
Jupiter Life
IPO
Financial Report >> |
₹ 735.00 | ₹ 1,075.25 | 46.29% | ₹ 1,439 | 96% |
|
Yatharth Hospital
IPO
Financial Report >> |
₹ 300.00 | ₹ 300.00 | 300.00% | ₹ 627 | 109% |
|
Global Health
IPO
Financial Report >> |
₹ 336.00 | ₹ 415.65 | 415.65% | ₹ 1,331 | 296% |
|
Rainbow Children's
IPO
Financial Report >> |
₹ 542.00 | ₹ 450.10 | 450.10% | ₹ 1,525 | 181% |
|
Vijaya Diagnostic
IPO
Financial Report >> |
₹ 531.00 | ₹ 619.30 | 619.30% | ₹ 1,120 | 111% |
|
Krsnaa Diagnostics
IPO
Financial Report >> |
₹ 954.00 | ₹ 990.75 | 990.75% | ₹ 845 | -11% |
|
Krishna Institute
IPO
Financial Report >> |
₹ 825.00 | ₹ 995.90 | 995.90% | ₹ 750 | 354% |
|
Nureca Limited
IPO
Financial Report >> |
₹ 400.00 | ₹ 666.65 | 666.65% | ₹ 237 | -41% |
|
Metropolis Healthcare
IPO
Financial Report >> |
₹ 880.00 | ₹ 959.55 | 959.55% | ₹ 1,950 | 122% |
|
Aster DM
IPO
Financial Report >> |
₹ 190.00 | ₹ 179.85 | 179.85% | ₹ 592 | 211% |
|
Shalby Limited
IPO
Financial Report >> |
₹ 248.00 | ₹ 239.25 | 239.25% | ₹ 209 | -16% |
|
Advanced Enzyme
IPO
Financial Report >> |
₹ 896.00 | ₹ 1,178.30 | 1178.30% | ₹ 348 | 94% |
|
Thyrocare Technologies
IPO
Financial Report >> |
₹ 446.00 | ₹ 618.10 | 618.10% | ₹ 1,268 | 184% |
|
Healthcare Global
IPO
Financial Report >> |
₹ 218.00 | ₹ 170.95 | 170.95% | ₹ 587 | 169% |
|
Narayana Hrudayalaya
IPO
Financial Report >> |
₹ 250.00 | ₹ 336.70 | 336.70% | ₹ 1,983 | 693% |
|
Dr. Lal
IPO
Financial Report >> |
₹ 550.00 | ₹ 824.15 | 824.15% | ₹ 3,026 | 450% |
|
Talwalkars Better
IPO
Financial Report >> |
₹ 128.00 | ₹ 162.60 | 162.60% | [●] | 0.00% |
|
Syncom Healthcare
IPO
Financial Report >> |
₹ 75.00 | ₹ 87.85 | 87.85% | [●] | 0.00% |
|
Lotus Eye
IPO
Financial Report >> |
₹ 38.00 | ₹ 35.50 | 35.50% | ₹ 74 | 94% |
|
Fortis Healthcare
IPO
Financial Report >> |
₹ 108.00 | ₹ 100.00 | 100.00% | ₹ 851 | 688% |
|
JHS Svendgaard
IPO
Financial Report >> |
₹ 58.00 | ₹ 57.05 | -1.64% | ₹ 12 | -79% |
Nephrocare Health Services IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
The peers of
Nephrocare Health Services ,
include other listed companies operating in the
(Healthcare) segment.
These peer companies typically
offer similar services Some of the notable peers as per the DRHP of this
company
are
Nephrocare Health Services Limited ,
Narayana Health
Jupiter Life Line Hospitals Limited ,
Rainbow Children's Medicare Limited ,
Dr Agarwals Health Care Limited ,
Vijaya Diagnostic Centre Limited ,
Dr. Lal PathLabs Limited ,
Metropolis Healthcare Limited ,
See the complete list of
current IPO
Peer Comparison is the method of evaluating an entity by comparing its performance, size of business form other entities operating in same industry or sector. It involves financial analysis by comparing key financial metrics like Profitability, Net worth, Market Capitalization and Leverage IPO Performance tracker
Peer comparison helps to identify companies in the same sector with a similar business. It helps to compare the financial performance and valuation against its listed peers. An investor or an analyst can decide whether the IPO price is justified when compared to its peers. An investor can make informed decision whether to apply to IPO or not on basis of peer comparison. Know the process of DRHP and Peer companies Information required to be disclosed in DRHP.
As of now 28 IPOs are listed in this sector indicating strong growth in this sector. Choosing the best IPO depends on factors like, financial performance, valuation, market trends and future growth plans. IPO Review and performance.
A good PE Ratio for Healthcare sector depends on various factors like, performance of the company, market conditions, company valuation and IPO Size. PE Ratio varies from sector to sector and company to company. Know the average PE Multiple in each sector.
Currently 28 companies are listed under Healthcare sector. Based on the latest data from the Stock Exchanges. Choose the Best Merchant Banker from the Merchant Banker List
Performance of companies depends on various factors like, profits, future plans, Market share, PE Ratio etc. By assessing these factors investor can make better investment decisions.Nephrocare Health Services Peer comparison provides IPO analysis of companies listed in this sector, on the basis of different Key performance indicators (KPI)like, Listing Gain of peers, current market price, PE Ratio and IPO Size.
Upcoming IPO refers to companies which have filed their DRHP with the Stock exchange and are awaiting approval from NSE or BSE 8 companies have filed their DRHP for IPO under Healthcare sector. .New IPO 2025-2026 and Upcoming IPO
PE Multiple is a metrics that is widely used for IPO Valuation. Merchant bankers in coordination with the company decides the PE Multiple.The PE Multiple depends on various factors and it should be analyzed in coordination with other financial metrics. Know the PE ratio of your company with PE Calculator provided by IPOplatform
Nephrocare Health Services operates in Healthcare and Offers Comprehensive Dialysis Care. The Issue is listed on BSE,NSE in Jul, 2025. Nephrocare Health Services IPO size was with Issue price of .
Merchant Banker(s) of Nephrocare Health Services IPO: Ambit Private Limited , ICICI Securities Limited , IIFL Securities Limited , Nomura Financial Advisory And Securities (India) Private Limited
Nephrocare Health Services IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Nephrocare Health Services IPO listed at a listing price of against the offer price of .
The current market price of Nephrocare Health Services is .
Why Us?
